Zhongfang Wang

13PUBLICATIONS
42CO-AUTHORS
Nanotoxicology, health and safetyInnate immunityInfant and child healthCancer therapy (excl. chemotherapy and radiation therapy)Medical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 14, 2026
Safety and Immunogenicity of a PD-1-Enhanced HIV-1 Therapeutic DNA Vaccine: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Phase I Clinical Trial in People With HIV-1 on Antiretroviral Therapy.

|Mar 12, 2026
Influenza virus infection drives upregulation of CD84 across a broad range of immune cells.

Xiaoxiao Jia, Isabelle Jh Foo, Hayley A McQuilten

|Mar 07, 2026
Complement Hyperactivation Is Mediated by Alternative and Lectin Pathways During Early Phase of Severe Vaccination-Omicron BA.5 Infection.

Jinpeng Cao, Gang Yang, Tingting Cui

|Mar 02, 2026
Extensive Immunological and Inflammatory Perturbation Underpins the Respiratory Sequelae of Postacute COVID-19.

Gang Yang, Jinpeng Cao, Shidong Deng

|Dec 08, 2025
Comprehensive profiling of smoke-induced T cells in mice implicates clonal γδT17 cells as a hallmark of COPD.

Xinyue Mei, Junxiang Wang, Yuan Wang

|Sep 30, 2025
Developing an eVLP mRNA vaccine for respiratory syncytial virus with enhanced pre-fusion targeting humoral responses.

Lei Sun, Mengting Huang, Simin Feng

Pageof 3

Frequent Collaborators

1 joint publications

Daxiang Chen

1 joint publications

Nanshan Zhong

1 joint publications

Zhuxiang Zhao

1 joint publications

Huimeng Wang